Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LH · against 588 other Healthcare companies listed in US-listed
Ranked #113 of 589 · scores higher than 80% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 60–69, including LH · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | LH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 3.4% | -4.3% | 81% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 6.6% | -0.8% | 77% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 4.0% | -2.3% | 78% | 20% | |
| Book yieldHigher is better · 587 reported | 30.1% | 25.9% | 56% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 109 | 243M USD | 64 | 56 | |
| 109 | 50.2B USD | 64 | 49 | |
| 109 | 16.8B USD | 64 | 75 | |
| 109 | 966M USD | 64 | 33 | |
| 113 | 28.7B USD | 63 | 52 | |
| 113 | 116.5B USD | 63 | 57 | |
| 113 | 2.2B USD | 63 | 66 | |
| 113 | 10.4B USD | 63 | 70 | |
| 113 | 884M USD | 63 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score